Searched for
GLAXOSMITHKLINE PHARMACEUTICALS STOCKS
These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of up to 26%- More macro headwinds on the cards? Tackle them with core principles: 6 pharma stocks with upside potential of up to 28%
- Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 22%
- Long-term Investing: Ecosystem with an edge called India; 12 large- mid- and small-cap stocks with upside potential of up to 34%Tactical investing should not be confused with long-term investing. In a world where geopolitical risk, commodity shocks, and uncertainty a...23 May, 2026, 10.24 PM IST
- These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of up to 25%Here’s a thing investors in equity need to keep in mind. A large part of the upmove one might see in the next one or two trading sessions w...18 May, 2026, 10.31 PM IST
- I-Sec upgrades GlaxoSmithKline Pharma to Add, lowers target price to Rs 2,250ICICI Securities has raised its rating on GlaxoSmithKline Pharmaceuticals to Add from Hold with a new target price of Rs 2250. GSK Pharma's...19 Feb, 2025, 09.51 AM IST
- GlaxoSmithKline Pharma Q4 Results: Firm posts net loss at Rs 55 croreRevenue from operations rose to Rs 810 crore for the fourth quarter compared to Rs 744 crore in the year-ago period, GlaxoSmithKline Pharma...17 May, 2022, 12.25 PM IST
- GSK Pharma sheds 2% as Q3 profit drops, expenses riseTotal income in October-December 2021 stood at Rs 826.24 crore as compared with Rs 805.89 crore in the year-ago period, PTI reported.08 Feb, 2022, 10.45 AM IST
- Neutral on GSK Pharma, target price Rs 1355: Motilal OswalGlaxoSmithKline Pharmaceuticals Ltd., incorporated in the year 1924, is a Large Cap company (having a market cap of Rs 26851.70 Crore) oper...29 Sep, 2020, 10.45 AM IST
- Reduce GlaxoSmithKline Pharma, target price Rs 1539: ICICI SecuritiesGlaxoSmithKline Pharmaceuticals Ltd., incorporated in the year 1924, is a Large Cap company (having a market cap of Rs 29900.17 Crore) oper...16 Sep, 2020, 12.07 PM IST
- GlaxoSmithKline Pharmaceuticals to sell Thane land for Rs 555 croreThe proposed sale is subject to receipt of all statutory and regulatory approvals from the concerned authorities and signing of the definit...23 Sep, 2017, 10.30 AM IST
- GlaxoSmithKline Pharmaceuticals to sell Thane land for Rs 555 croreThe proposed sale is subject to receipt of all statutory and regulatory approvals from the concerned authorities and signing of the definit...23 Sep, 2017, 12.41 AM IST
- GlaxoSmithKline Pharma Q1 dips 5 per cent to Rs 93 croreNet sales declined to Rs 621.85 crore for the first quarter, as compared to Rs 654.96 crore in the same period of previous financial year.31 Jul, 2015, 03.35 PM IST
- GSK Pharma shares slump over 8% ahead of closure of open offerShares of GlaxoSmithKline Pharmaceuticals slumped over 8 per cent as the open offer made by its UK-based parent to acquire additional stake...05 Mar, 2014, 06.05 PM IST
- $1 billion bet: GSK Pharma a short-term sell, long-term buy, say expertsThe stock is at rich valuations despite low sales and profit growth. The open offer by its parent firm is attractively priced, say experts.16 Dec, 2013, 04.28 PM IST
- GSK Consumer hits record high on parent company's plan to raise its stakeGSK Consumer surged 20% to hit its record high in early trade after its parent plans to raise its stake in Indian arm to 75%.26 Nov, 2012, 10.11 AM IST
- GlaxoSmithKline Pharmaceuticals Q3 net up 4.44% at Rs 152.34 croreGlaxoSmithKline today reported 4.44 per cent rise in net profit at Rs 152.34 crore for the quarter ended September 30, 2012 on back of robu...09 Nov, 2012, 03.05 PM IST
- Buy GlaxoSmithKline as it can head to 2005 levels: Mitesh ThackerGlaxoSmithKline Pharmaceuticals has gone through a corrective movement and is now probably in a technical rally or a short term retracement...30 Dec, 2011, 11.15 AM IST
- GlaxoSmithKline FY10 net profit up 10.37 pc to Rs 560.57 crGlaxoSmithKline Pharmaceuticals today said its consolidated net profit rose by 10.37 per cent to Rs 560.57 crore for the year ended Decembe...14 Feb, 2011, 07.08 PM IST
- GlaxoSmithKline 2010 net profit up 10.37 pc to Rs 560.57 crThe company's board of director recommended a dividend of Rs 40 per share for the year ended December 31, 2010, in its meeting today.14 Feb, 2011, 02.49 PM IST
Load More
